Complex array of cytokines released by vasoactive intestinal peptide

被引:53
作者
Brenneman, DE
Phillips, TM
Hauser, J
Hill, JM
Spong, CY
Gozes, I
机构
[1] NICHHD, Sect Dev & Mol Pharmacol, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA
[2] NIH, Ultramicro Analyt Immunochem Resource, Div Bioengn & Phys Sci, Off Res Serv,Off Director, Bethesda, MD 20892 USA
[3] Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel
关键词
interleukin-3; granulocyte colony stimulating factor; tumor necrosis factor-alpha; macrophage colony stimulating factor; interleukin-6;
D O I
10.1016/S0143-4179(03)00022-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-alpha, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15-30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50%) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC50's for the release of G-CSF and TNF-α; however, the maximal release was 4-6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC50's of VIP were 3-30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system. (C) 2003 Published by Elsevier Science Ltd.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 58 条
  • [1] Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides
    Ashur-Fabian, O
    Giladi, E
    Brenneman, DE
    Gozes, I
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 1997, 9 (03) : 211 - 222
  • [2] Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide
    Bassan, M
    Zamostiano, R
    Davidson, A
    Pinhasov, A
    Giladi, E
    Perl, O
    Bassan, H
    Blat, C
    Gibney, G
    Glazner, G
    Brenneman, DE
    Gozes, I
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) : 1283 - 1293
  • [3] Blondel O, 2000, J NEUROSCI, V20, P8012
  • [4] NEURONAL CELL KILLING BY THE ENVELOPE PROTEIN OF HIV AND ITS PREVENTION BY VASOACTIVE INTESTINAL PEPTIDE
    BRENNEMAN, DE
    WESTBROOK, GL
    FITZGERALD, SP
    ENNIST, DL
    ELKINS, KL
    RUFF, MR
    PERT, CB
    [J]. NATURE, 1988, 335 (6191) : 639 - 642
  • [5] CYTOKINE REGULATION OF NEURONAL SURVIVAL
    BRENNEMAN, DE
    SCHULTZBERG, M
    BARTFAI, T
    GOZES, I
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 454 - 460
  • [6] VASOACTIVE-INTESTINAL-PEPTIDE - A NEUROTROPHIC RELEASING AGENT AND AN ASTROGLIAL MITOGEN
    BRENNEMAN, DE
    NICOL, T
    WARREN, D
    BOWERS, LM
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 25 (03) : 386 - 394
  • [7] VASOACTIVE-INTESTINAL-PEPTIDE AND ELECTRICAL-ACTIVITY INFLUENCE NEURONAL SURVIVAL
    BRENNEMAN, DE
    EIDEN, LE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (04) : 1159 - 1162
  • [8] NONNEURONAL CELLS MEDIATE NEUROTROPHIC ACTION OF VASOACTIVE-INTESTINAL-PEPTIDE
    BRENNEMAN, DE
    NEALE, EA
    FOSTER, GA
    DAUTREMONT, SW
    WESTBROOK, GL
    [J]. JOURNAL OF CELL BIOLOGY, 1987, 104 (06) : 1603 - 1610
  • [9] INTERLEUKIN-1-ALPHA AND VASOACTIVE-INTESTINAL-PEPTIDE - ENIGMATIC REGULATION OF NEURONAL SURVIVAL
    BRENNEMAN, DE
    HILL, JM
    GLAZNER, GW
    GOZES, I
    PHILLIPS, TW
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1995, 13 (3-4) : 187 - 200
  • [10] BRENNEMAN DE, 1993, J PHARMACOL EXP THER, V266, P1029